Receipt of notification from a shareholder under Article 69 of the Act on Public Offering
The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (“Company”) hereby announces that on 12 June 2017 it received a notification pursuant to Article 69(1)(2) in conjunction with Article 87(1)(2)(a) of the Act of 29 July 2005 on public offering and conditions for the introduction of financial instruments to organised trading system and on public companies (consolidated text: Journal of Laws of 2016, item 1639) from the shareholder Aviva Investors Poland Towarzystwo Funduszy Inwestycyjnych S.A. acting:
- on its own behalf as an entity authorised to manage portfolios of investment funds and as a body authorised to represent investment funds;
- for and on behalf of Aviva Investors Fundusz Inwestycyjny Otwarty and Aviva Investors Specjalistyczny Fundusz Inwestycyjny Otwarty (“Funds”);
regarding a reduction in the share of the Funds in the total number of votes in the Company below 5% as a result of selling shares in the Company on 8 June 2017 (“Transaction”).
As a result of the Transaction, the Funds hold 173,879 shares of the Company representing 4.82% of the Company’s share capital and carrying 173,879 votes, constituting 4.82% of the total number of votes at the Company’s general meeting.
Before the Transaction, the Funds held 192,216 shares of the Company representing 5.33% of the Company’s share capital and carrying 192,216 votes, constituting 5.33% of the total number of votes at the Company’s general meeting.
The Funds do not have any subsidiaries which hold shares or rights to shares of the Company